Early implementation of treatment with biologic or targeted synthetic DMARDs after methotrexate failure did not prevent the ...

Early initiation of biologic therapy in patients with Crohn’s disease (CD) is associated with higher rates of transmural healing and leads to improved long-term outcomes. In CD, early initiation of ...

Interleukin-23 inhibitors, prior treatment history, and Psoriasis Area and Severity Index scores may be predictive of time to disease relapse among patients with psoriasis who achieved clinical ...

has approved the Biologics License Application (BLA) for its HPC, Cord Blood product REGENECYTE™, a vital cord blood stem cell therapy for transplantation in patients with blood and immune ...

The FDA received a biologics license application for accelerated approval of RP1 plus nivolumab for advanced, pretreated ...

Whether you’re looking for a psoriasis treatment with fewer side effects than your current therapy or it affects your daily life, you may want to switch to a biologic. Speaking with your doctor ...

which are critical for administering cell therapy. This constraint, alongside Turnstone Biologics' slower patient enrollment rates, presents significant hurdles for the company's progress.

REGENECYTE™ is an allogeneic hematopoietic stem cell therapy derived from human umbilical cord blood. It is approved for unrelated donor hematopoietic progenitor cell transplantation procedures in ...

REGENECYTE™ is an allogeneic hematopoietic stem cell therapy derived from human umbilical cord blood. It is approved for unrelated donor hematopoietic progenitor cell transplantation procedures ...

A biologic drug is one that’s made from a living thing. Vaccines, donated blood, gene therapy, and monoclonal antibodies are examples of biologic drugs. Many are made from bacteria in a lab.

the number of individuals using biologic therapy, biologic switching, and the time between treatment initiation and interruption. This data can be utilized to calculate drug survival, a surrogate ...